MLchartDataset catalogue

Tisotumab vedotin

Term · Oncology and biomedicine · MLC-T-ONC-008723

A drug used to treat adults with cervical cancer that has come back or has spread. It is used in patients whose cancer got worse during or after chemotherapy. It is also being studied in the treatment of other types of cancer. Tisotumab vedotin contains a monoclonal antibody that binds to a protein called tissue factor, which is found on some cancer cells. It also contains an anticancer drug, which may help kill cancer cells. Tisotumab vedotin may also prevent the growth of new blood vessels that tumors need to grow. It is a type of antibody-drug conjugate and a type of antiangiogenesis agent. Also called Tivdak.

Table 1. Record
IdentifierMLC-T-ONC-008723
FieldOncology and biomedicine
SynonymsTivdak
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008723",
  "term": "Tisotumab vedotin",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with cervical cancer that has come back or has spread. It is used in patients whose cancer got worse during or after chemotherapy. It is also being studied in the treatment of other types of cancer. Tisotumab vedotin contains a monoclonal antibody that binds to a protein called tissue factor, which is found on some cancer cells. It also contains an anticancer drug, which may help kill cancer cells. Tisotumab vedotin may also prevent the growth of new blood vessels that tumors need to grow. It is a type of antibody-drug conjugate and a type of antiangiogenesis agent. Also called Tivdak.",
  "synonyms": [
    "Tivdak"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tisotumab-vedotin/"
}

Record 16,394 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.